Welcome to the LEQVIO® Service Center

We aim to provide simple, reliable, and supportive solutions to help your patients access LEQVIO.

LEQVIO can be acquired in 3 ways, which in some cases is dictated by your patient's health plan:

Form with dollar sign

Buy-and-bill with in-office administration

Syringe

Referral to an alternate injection/infusion center

Pharmacy

Specialty pharmacy with in-office administration

Whichever way you go about getting LEQVIO, we're ready to assist you.

Learn More
Call center employee

Got 2 minutes? Answer up to 2 questions, and we'll create a custom support guide for you.

The custom support guide provides helpful information and resources about the process for acquiring LEQVIO
and the services available to your office.

Get Started
Quiz Header 1

How will you order and administer LEQVIO®?

ClickTap + to learn more about each acquisition method. Select the one that applies.

I am going to acquire through buy-and-bill and administer in my office

Buy-and-bill is a method for acquiring specialty drugs covered under the Medical Benefit.

Your office purchases LEQVIO from an authorized distributor, receives and administers the product, then submits for reimbursement for the product cost and the administration fee.

I will refer to an alternate injection/infusion center or a hospital outpatient department for administration

Your office will refer the patient to another site to receive LEQVIO, which may include an injection/infusion clinic or center, hospital outpatient department, or another physician's office. The site is responsible for acquiring the product and submitting for reimbursement.

I am going to acquire through specialty pharmacy and administer in my office

Your office orders from a specialty pharmacy, administers the product, then submits a claim for the administration fee. The specialty pharmacy works with the patient on their out-of-pocket responsibility for the product.

Product ordered through specialty pharmacy must be given to the specific patient for whom it was ordered (unlike with buy-and-bill, in which the product can be given to any patient for whom it's prescribed).

I am not sure

Next
Call center employee
Quiz Header 2

Buy-and-bill


Which services do you plan to utilize?

ClickTap + to learn more about each service. Select all that apply.

Benefits verification

A benefit verification is the process by which the LEQVIO® Service Center confirms whether a patient has access to the product and if any plan requirements must be met before therapy can be received.

Based on patient eligibility, the LEQVIO Service Center may be able to offer information regarding additional assistance programs for your patients who are uninsured or underinsured.

Prior authorization and appeals support

Insurance plans may put restrictions in place. The Service Center has experience with these processes and can provide resources and support.

Product acquisition information and resources

Patient coverage and insurance plan requirements may dictate how you acquire LEQVIO® for your patients. The Service Center can provide helpful information about this process.

Co-pay support

The LEQVIO® Co-pay Program is available for eligible commercially insured patients.

Billing and coding support

To receive reimbursement for the product and administration costs, proper coding practices should be followed. The Service Center can provide information and resources regarding billing and coding.

Novartis cannot guarantee insurance coverage or reimbursement. Coverage and reimbursement may vary significantly by payer, plan, patient, and setting of care.

Next
Call center employee
Quiz Header 3

Buy-and-bill

+1


Thanks for your responses!

Based on your selections, we've created a custom
support guide just for you.

Generate your custom guide below, and feel free to
reach out if you have any questions.

Generate Custom Guide
Call center employee
Quiz Header 4

Alternate injection/infusion center or a hospital outpatient department


Thanks for your responses!

Based on your selections, we've created a custom
support guide just for you.

Generate your custom guide below, and feel free to
reach out if you have any questions.

Generate Custom Guide
Call center employee
Quiz Header 4

I am not sure


Thanks for your responses!

Based on your selections, we've created a custom
support guide just for you.

Generate your custom guide below, and feel free to
reach out if you have any questions.

Generate Custom Guide
Call center employee

FREQUENTLY REQUESTED RESOURCES

thumbnail image of LEQVIO Start Form

Start Form

Download PDF
thumbnail image of Free Trial Offer order

Free Trial Offer Order Form

Download PDF
thumbnail image of Prior Authorization & Appeals Guide

Prior Authorization & Appeals Guide

Download PDF
thumbnail image of Distribution & Acquisition Flashcard

Distribution
& Acquisition Flashcard

Download PDF
thumbnail image of Billing & Coding Guide

Billing & Coding Guide

Download PDF

Expand

Collapse

Up Arrow Down Arrow
IMPORTANT SAFETY INFORMATION

Adverse reactions in clinical trials (≥3% of patients treated with LEQVIO® and more frequently than placebo) were injection site reaction, arthralgia, urinary tract infection, diarrhea, bronchitis, pain in extremity and dyspnea.

Adverse reactions led to discontinuation in 2.5% and 1.9% of LEQVIO- and placebo-treated patients, respectively. Discontinuation due to injection site reactions, which included injection site pain, erythema and rash, were 0.2% and 0% of LEQVIO- and placebo-treated patients, respectively.

Please click here for LEQVIO full Prescribing Information.

INDICATION

LEQVIO (inclisiran) injection is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) who require additional lowering of low-density lipoprotein cholesterol (LDL-C). Limitations of Use: The effect of LEQVIO on cardiovascular morbidity and mortality has not been determined.

Please click here for LEQVIO full Prescribing Information.